Cardiovascular diseases

Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Current study results indicate that HIV/AIDS patients are disproportionately affected by cardiovascular diseases (CVDs) despite effective viral load suppression with antiretroviral therapy (ART). The mechanisms underlying this relationship are complex and incompletely understood, involving a interplay of traditional cardiovascular risk factors, chronic inflammation, and metabolic side effects of ART.

Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Current study results indicate that HIV/AIDS patients are disproportionately affected by cardiovascular diseases (CVDs) despite effective viral load suppression with antiretroviral therapy (ART). The mechanisms underlying this relationship are complex and incompletely understood, involving a interplay of traditional cardiovascular risk factors, chronic inflammation, and metabolic side effects of ART.